Stefania Eufemia Lutrino
Stefania Eufemia Lutrino publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology and Cholangiocarcinoma and Gallbladder Cancer Studies.
- World rank
- #3,752,294 of 7,710,434 ranked researchers
- Rank in Italy
- #127,239 of 242,206
- Works
- 39
- Citations
- 432
- Citations per work
- 11.1
What does Stefania Eufemia Lutrino research?
Stefania Eufemia Lutrino's work is mostly in Medicine (79%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3178.9%
- Medicine3178.9%
- Everything else512.9%
- Life Sciences38.2%
- 1Oncology42% of their works
- 2Pulmonary and Respiratory Medicine19% of their works
- 3Surgery16% of their works
- 4Cancer Research6% of their works
- 5Genetics2% of their works
- 6Molecular Biology2% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastric Cancer Management and Outcomes
- Pancreatic and Hepatic Oncology Research
- Gallbladder and Bile Duct Disorders
- Colorectal Cancer Surgical Treatments
- Cancer Genomics and Diagnostics
Which keywords describe Stefania Eufemia Lutrino's research?
The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, Cholangiocarcinoma, Clinical Practice Guidelines, Neoadjuvant Therapy, Biliary Tract Cancer and Chemotherapy-Induced Peripheral Neuropathy.
- Mutational Signatures
- Rectal Cancer
- Surgical Complications
- ERCP
- Gastric Cancer
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- Neoadjuvant Therapy
- Cholangiocarcinoma
- Cetuximab
- Chemotherapy
- KRAS Mutations
- Clinical Practice Guidelines
- Biliary Tract Cancer
- Intrahepatic Cholangiocarcinoma
- Endoscopic Resection
- Cholecystitis
- Pancreatic Cancer
- Preoperative Chemoradiotherapy
- Cancer Genomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy253 topics
- Cetuximab141 topic
- KRAS Mutations141 topic
- Cholangiocarcinoma132 topics
- Clinical Practice Guidelines102 topics
- Neoadjuvant Therapy92 topics
- Biliary Tract Cancer81 topic
- Chemotherapy-Induced Peripheral Neuropathy81 topic
- Intrahepatic Cholangiocarcinoma81 topic
- Taxanes81 topic
- Endoscopic Resection61 topic
- Gastric Cancer61 topic
- Cholecystitis51 topic
- ERCP51 topic
- Pancreatic Cancer51 topic
- Surgical Complications51 topic
- Preoperative Chemoradiotherapy41 topic
- Rectal Cancer41 topic
- Cancer Genomics31 topic
- Mutational Signatures31 topic
Where does Stefania Eufemia Lutrino work?
Stefania Eufemia Lutrino's main affiliation in the publication record is University of Udine, Italy.
How many publications and citations does Stefania Eufemia Lutrino have?
OpenAlex counts 39 works and 432 citations for Stefania Eufemia Lutrino, an h-index of 12, ranking #3,752,294 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Stefania Eufemia Lutrino. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.